Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Defense was posted on June 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NextSeq 1000

Closed
FY26-0778-1Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity is pursuing a sole-source acquisition under FAR 12.102(a) for the NextSeq 1000 Sequencing System from ILLUMINA, INC, as it is the only source capable of meeting the mission-critical requirements of the Armed Forces Medical Examiner System DNA Operations at Dover Air Force Base, Delaware. The system must deliver an integrated DNA-to-analysis workflow capable of rapid sequencing of targeted panels, whole mitochondrial genomes, and SNP analysis in a single run, with performance benchmarks including at least 90% of bases at Q30 quality, 2x300 bp read lengths, up to 120 Gb per run, and run times between 8 and 42 hours. The procurement includes the instrument with 288 GB RAM and 3.8 TB SSD, onboard Linux CentOS software, initial XLEAP-SBS reagent kits, a three-year Silver Support Plan commencing after the initial one-year manufacturer warranty, and full installation with Installation and Operational Qualification per manufacturer standards. The system must also integrate with the AFMES Laboratory Information Management System for seamless .txt worklist import and data export, maintain backward compatibility with current forensic assays, and provide a documented upgrade path to the NextSeq 2000 platform. This acquisition is conducted under simplified acquisition procedures with no set-aside restrictions and falls under NAICS code 334516, which has a small business size standard of 1,000 employees. The contract requires total vendor accountability for shipping, handling, and insurance of the system to Dover AFB, with no specific packaging, preservation, or labeling standards defined beyond the requirement for RFID tracking of consumables. Technical capability statements, including detailed cost information, must be submitted by July 13, 2026, at 9:00 AM EST via email in PDF, Word, or Excel format to the designated point of contact. While the presolicitation notice identifies Illumina as the only technically acceptable provider, any responses received will be evaluated to determine whether competition is warranted, though the government retains full discretion in deciding whether to proceed without competition. No formal contract type, pricing, or clauses have been finalized, as this phase remains informational and preparatory, with award contingent on vendor submissions and government determination of sole-source justification.

General Info

Sole source award to Illumina, Inc. for NextSeq 1000 system at Dover AFB, no competition, extended warranty, submissions due July 13, 2026.

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Place of Performance

Dover AFB, DE, USA

Set-Aside

NONE

Documents

2

Minimum Essential Characteristics for Illumina NextSeq 1000 Sequencing System

PDF, High priority: read this firstmec
High

SOW for Illumina NextSeq 1000 Sequencing System

PDF, High priority: read this firstsow
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Army Medical Resources Acq Activity
Contacts1 person available
OfficeFORT DETRICK, MD, 21702, USA
Office AddressFORT DETRICK, MD, 21702, USA
Contacts

Full Description

Show more

The Defense Health Agency Contracting Activity (DHACA) in Fort Detrick, MD intends to negotiate on a sole source basis (IAW RFO 12.102(a)) with ILLUMINA, INC 5200 Illumina Way, San Diego, CA 9212-4616 as the only responsible source that can provide the NextSeq 1000 Sequencing System. This is a Presolicitation notice in accordance with RFO 5.101.



The equipment provided by ILLUMINA INC is the only source that provides DHACA with the NextSeq 1000 Sequencing System and extended warranty used at the Armed Forces Medical Examiner System DNA Operations (AFMES-DNA OPS) to support their mission. Its fast, integrated DNA-to-analysis workflow allows for the rapid sequencing of targeted panels, whole mitochondrial genomes, and supports single nucleotide polymorphism (SNP) analysis in a single run.  The extended warranty shall commence when 12-month Manufacturer Warranty expires.



This acquisition is being conducted under simplified acquisition procedures. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 334516 with a Small Business Size Standard of 1,000 employees. This presolicitation notice is not a request for competitive proposals and no solicitation document exists for this requirement. However, any parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same service. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.



Based on the above information, the only technically acceptable subscription can be provided by ILLUMINA INC .
Submit email capability statements (using PDF, MS Word, Excel attachments) to Alicia Maldonado Torres at contact@example.gov. Statements are due no later than 09:00 AM EST on 13 July 2026

More opportunities from Department Of Defense → Army Medical Resources Acq Activity

Same awarding agency

NAICS: 325413
New
Federal
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
Solicitation # HT942627QE003
The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.
In-Vitro Diagnostic Substance Manufacturing

POSTED

6 days ago

DEADLINE

in 8 days
View Details
NAICS: 813920
Federal
Biomedical Research Application Evaluation and Support (BRAES)
Solicitation # HT942727RE006
The Biomedical Research Application Evaluation and Support (BRAES) contract is a performance-based, non-commercial Multiple Award Indefinite Delivery Indefinite Quantity (MA-IDIQ) solicitation issued by the Defense Health Agency for the Congressionally Directed Medical Research Programs. With a ceiling cost of 137 million dollars and an estimated period of performance from January 2027 to January 2032, the contract supports the evaluation of biomedical research applications. The scope is divided into four primary areas: funding opportunity announcement set-up, oversight of application receipt and processing, application compliance review, and scientific merit peer review. While the first three tasks are awarded to a single vendor via the eBRAP task order, the scientific peer review tasks are awarded to multiple vendors through Science Administration and Management (SAM) task orders, which require the operation of a secure, contractor-owned, contractor-operated (COCO) web-based system. The government will utilize a Highest Technically Rated with a Fair and Reasonable Cost/Price approach to select approximately three awardees. Evaluation factors include technical approach, management approach, past performance, and small business participation, with cost and price serving as the final check for the highest-rated proposals. Key requirements for offerors include an active SAM registration, a CMMC Level 1 self-assessment, and the submission of a five-volume proposal by December 2, 2026. Contract administration involves a mix of Cost Plus Fixed Fee and Firm Fixed Price arrangements, with invoicing processed through the Wide Area Workflow system. Performance is monitored via Quality Assurance Surveillance Plans using random sampling and 100 percent inspection to determine CPARS ratings based on accuracy and schedule adherence.
Professional Organizations

POSTED

10 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
Federal
Mild Traumatic Brain Injury (mTBI) Blast Injury Prevention Standards Request for Information
Solicitation # CB4_SW_mTBI_RFI
The Army Medical Resources Acq Activity, specifically the USAMRDC and the Department of War Blast Injury Research Coordinating Office in collaboration with The MITRE Corporation, has issued a Request for Information regarding Mild Traumatic Brain Injury blast injury prevention standards. This initiative aims to identify existing and emerging injury criteria, thresholds, standards, and models to inform the Military Health System Blast Injury Prevention Standards Recommendation process. The primary goal is to gather biomedically valid data, such as dose response curves and injury thresholds, to improve health hazard assessments, survivability assessments, and the development of protection systems for service members exposed to explosive weapons. This notice is issued solely for information and program planning purposes and does not constitute a formal solicitation for proposals. In accordance with FAR 15.201(e), responses are not considered offers and cannot be accepted to form a binding contract, nor will the government provide reimbursement for costs associated with participating. Interested parties from industry, academia, and other federal agencies are encouraged to submit relevant publications, reports, and images through a specific online submission process. The primary point of contact for this effort is Contract Specialist Skylar Wells, and the response deadline is November 3, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

13 days ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS